Ask sufficient profitable entrepreneurs how they constructed their corporations and a sample begins to emerge. Most didn’t start with a groundbreaking product. They began with an issue they couldn’t ignore.
It’s a lesson billionaire entrepreneur Mark Cuban has talked about for years. The most important alternatives usually come from fixing actual ache factors quite than chasing traits. The entrepreneurs who win are normally those who discover an issue that frustrates individuals, prices cash or creates inefficiencies after which builds an answer round it.
That philosophy is simple to see within the journey of Andre EstevaCEO and co-founder of ArteraAI.
Right now, Esteva is likely one of the most acknowledged names in healthcare AI. He was not too long ago named to TIME Journal’s 2025 TIME100 Well being checklistrecognizing the world’s most influential individuals in well being. His firm, ArteraAI, was named one in all TIME’s Finest Innovations and chosen by the World Financial Discussion board as a World Innovator.
However neither began with a quest to construct an AI firm. It began with an issue.
Trying Past The Expertise
Synthetic intelligence has turn out to be one of many hottest matters in enterprise. Each week appears to carry a brand new AI product, platform or startup promising to revolutionize an business.
Esteva believes the dialog ought to begin someplace else.
“AI is essentially the most transformative know-how we’ve had in a very long time,” he mentioned throughout a latest interview. “The impression AI has had on the healthcare system, I consider, is as highly effective as computer systems have had on the healthcare system.”
That’s a big assertion coming from somebody who has spent a lot of his profession working on the intersection of healthcare and know-how. Earlier than launching ArteraAI, Esteva served as Head of Medical AI at Salesforce Analysis and held engineering roles at Google Analysis, GE Healthcare and Sandia Nationwide Laboratories. His analysis has been cited greater than 25,000 instances and helped show among the earliest examples of AI acting at ranges corresponding to physicians in particular medical duties.
Regardless of these accomplishments, Esteva noticed a bigger problem. Medication has made outstanding advances during the last a number of a long time, but physicians nonetheless face tough selections when figuring out the perfect therapy choices for particular person most cancers sufferers. Two sufferers with comparable diagnoses can reply very in another way to the identical remedy. That uncertainty grew to become the issue he wished to resolve.
Serving to Medical doctors Personalize Remedy
Not like many healthcare AI corporations targeted on prognosis, ArteraAI focuses on therapy selections.
“Artera doesn’t diagnose most cancers,” Esteva mentioned. “We assist personalize therapies.”
It’s an essential distinction. The corporate’s know-how helps physicians make extra knowledgeable therapy selections by analyzing pathology pictures and medical data via synthetic intelligence.
The objective isn’t to interchange docs. It’s to present them higher data. In healthcare, that issues. Sufferers need confidence that they’re receiving the proper therapy. Physicians need extra insights to assist complicated selections. Healthcare techniques need higher outcomes whereas managing prices.
In accordance with Esteva, these targets don’t must compete with one another. “Artera helps everybody,” he mentioned. “Sufferers, clinicians and the healthcare system.”
That’s one purpose ArteraAI has gained traction within the healthcare neighborhood. The corporate’s ArteraAI Prostate Take a look at is presently the one predictive short-term androgen deprivation remedy (ADT) device beneficial by the Nationwide Complete Most cancers Community Medical Follow Tips in Oncology for prostate most cancers care.
The check can be absolutely reimbursed below Medicare’s established cost pricewhich means lined Medicare Half B sufferers haven’t any out-of-pocket prices.
For a lot of startups, constructing the know-how is the laborious half. For healthcare corporations, attaining medical adoption and reimbursement will be equally difficult.
A Lesson For Entrepreneurs
One of many largest errors entrepreneurs make is falling in love with a product earlier than absolutely understanding the issue.
The strongest companies usually do the alternative. They turn out to be obsessive about fixing a problem that individuals face each day.
That problem is likely to be serving to customers discover more healthy beverage choices. It is likely to be making house loans extra environment friendly. Or it could possibly be serving to physicians make extra personalised therapy selections for most cancers sufferers. The business doesn’t matter practically as a lot as the issue. For Esteva, the chance wasn’t merely synthetic intelligence. It was utilizing AI to handle a problem that impacts thousands and thousands of sufferers and households. That’s what separates many profitable corporations from the remainder.
Expertise adjustments. Markets evolve. Tendencies come and go. However companies that remedy significant issues have a means of staying related. As AI continues to reshape industries, the entrepreneurs who create lasting impression will not be those constructing essentially the most superior know-how. They will be the ones who perceive a easy fact that profitable founders have identified for many years: Discover an issue value fixing, and the chance usually follows.
